Daily news email for August 31, 2010 | Click here for updated news
SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.
Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com
PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!
|
BioSpace
India's Sun Pharmaceutical Industries Ltd Unit Gets Warning from US FDA
BTG plc Signs $16.6 Mln Deal To Sell Nycomed's Antivenom Drugs
Scientists Discover New Protein That Gets To the Roots of Obesity and Osteoporosis, Study Published in
Kythera Biopharmaceuticals and Bayer Corporation Unit Intendis, Inc. Enter Licensing and Development Agreement for Adipolytic Agent ATX-101; To Receive $43 Million Upfront And May Receive $330 Million More
Study Links Male Y Chromosome Variants with the Risk of Coronary Heart Disease, University of Leicester Study
|
BioSpace - Breaking News
Stromedix, Inc. Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary Fibrosis
Progenics Pharmaceuticals, Inc. to Present Preclinical Study of Novel Monoclonal Antibodies Against C. difficile at 2010
Naurex Inc.'s Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch
Neurotech Announces Initiation of Phase 1 Clinical Trial for AAD-2004, a Potent Spin Trapping Molecule and Microsomal Prostaglandin E Synthase-1 Inhibitor, Targeting Alzheimer's, Parkinson's, and Lou Gehrig's Disease
Boehringer Ingelheim Corporation Release: Combination Therapy of Telmisartan and Amlodipine Provides Significantly Better Blood Pressure Lowering Than Either Agent Alone
|
